Company Filing History:
Years Active: 2017-2023
Title: The Innovative Journey of Christopher Towles Lengerich
Introduction
Christopher Towles Lengerich, a prominent inventor based in Palo Alto, CA, has made significant contributions to the field of cardiovascular technology. With a portfolio of five patents, he demonstrates a commitment to advancing healthcare through innovative methods and systems.
Latest Patents
Lengerich's latest patents focus on a cutting-edge method for improving heart rate estimates by combining multiple measurement modalities. This invention provides systems and methods for determining the frequency of a cardiovascular pulse using both a continuously available physiological signal and a less available, more accurate physiological signal. When the second signal is present, it governs the determination of the pulse rate. Conversely, in the absence of the second signal, the first signal is utilized for pulse rate estimation. This dual approach allows for more accurate heart rate monitoring, showcasing Lengerich’s innovative mindset and dedication to improving cardiovascular health.
Career Highlights
Lengerich is associated with Verily Life Sciences LLC, a company focused on utilizing technology to enhance healthcare outcomes. His work involves developing sophisticated health monitoring systems that are pivotal in advancing medical research and patient care.
Collaborations
In his professional journey, Lengerich collaborates with key figures such as Mark Murphy and Raphael Cendrillon. Their combined expertise creates an environment ripe for innovation, as they endeavor to push the boundaries of medical technology and improve health-related metrics.
Conclusion
Christopher Towles Lengerich continues to stand out as a remarkable inventor in the realm of cardiovascular technology. His inventive spirit and strategic collaborations further demonstrate the importance of innovation in enhancing the healthcare industry. As he moves forward, his contributions are sure to shape the future of health monitoring and biomedical advancements.